Advertisement

AACR Report on the Impact of COVID-19 on Cancer Research and Patient Care
Posted: 02/15/2022 | By: Sarah Campen, PharmD

Question 1 of 5

Most patients with cancer develop a strong immune response to COVID-19 vaccines. However, patients receiving which of the following therapies may not be optimally protected (due to low antibody response)?

Choose 1

A
Rituximab
B
CAR T-cell therapy
C
Bevacizumab
D
Immune checkpoint inhibitors

CategoriesView All Quizzes

Tumor Type


Additional Topics



Conference Coverage